Literature DB >> 23566829

No association of functional variant in pri-miR-218 and risk of congenital heart disease in a Chinese population.

Xiaobo Gao1, Liping Yang, Yan Ma, Juhua Yang, Guican Zhang, Guoying Huang, Qiuyu Huang, Liangwan Chen, Fangmeng Fu, Yandan Chen, Dongmei Su, Yi Dong, Xu Ma, Cailing Lu, Xiaozhong Peng.   

Abstract

BACKGROUND: MiR-218 plays an important role in heart development in zebrafish. pri-miR-218 rs11134527 variant is associated with cervical cancer carcinogenesis. Therefore, we hypothesized that single nucleotide polymorphism (SNPs) in pri-miR-218 might influence susceptibility to sporadic congenital heart disease (CHD). METHODS AND
RESULTS: We conducted a case-control study of CHD in a Chinese population to test our hypothesis by sequencing and genotyping pri-miR-218 in 1116 CHD cases and 1219 non-CHD controls. We identified one SNP rs11134527 located in pri-miR-218 sequence. Logistic regression analyses showed that there was no significant association in genotype and allele frequencies of pri-miR-218 rs11134527 A/G polymorphism between CHD cases in overall or various subtypes and the control group. However, real-time PCR analysis showed that rs11134527 allele G significantly increased mature miR-218 expression. In vitro binding assays further revealed that the rs11134527 variant affects miR-218-mediated regulation of Robo1.
CONCLUSIONS: This is the first study to investigate the relationship between miR-218 and CHD cases. Our results demonstrate that the functional variant rs11134527 in pri-miR-218 has no major role in genetic susceptibility to sporadic CHD, at least in the population studied here.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23566829     DOI: 10.1016/j.gene.2013.03.119

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Association between miR-125a rs12976445 and survival in breast cancer patients.

Authors:  Lianghe Jiao; Jiaxin Zhang; Yuanyuan Dong; Bensong Duan; Hong Yu; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

2.  The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Lin Jiang; Chaofu Wang; Canlin Sun; Yumin Xu; Zhongqi Ding; Xueling Zhang; Junxing Huang; Hong Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Authors:  Dimitra-Ioanna Lampropoulou; Gerasimos Aravantinos; Konstantinos Laschos; Theodosis Theodosopoulos; Christos Papadimitriou; Maria Gazouli
Journal:  Int J Colorectal Dis       Date:  2019-10-09       Impact factor: 2.571

Review 4.  Genetic variants in microRNA genes: impact on microRNA expression, function, and disease.

Authors:  Sophia Cammaerts; Mojca Strazisar; Peter De Rijk; Jurgen Del Favero
Journal:  Front Genet       Date:  2015-05-21       Impact factor: 4.599

5.  A Single-Nucleotide Polymorphism in 3'-Untranslated Region of Endothelin-1 Reduces Risk of Dementia After Ischemic Stroke.

Authors:  Wanwan Ma; Qizhi Fu; Yanpeng Zhang; Zhen Zhang
Journal:  Med Sci Monit       Date:  2016-04-23

6.  APRISMA-compliant systematic review and meta-analysis determining the association of miRNA polymorphisms and risk of congenital heart disease.

Authors:  Xing-Yan Li; Kun Chen; Zheng-Tao Lv
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  miRVaS: a tool to predict the impact of genetic variants on miRNAs.

Authors:  Sophia Cammaerts; Mojca Strazisar; Jenne Dierckx; Jurgen Del Favero; Peter De Rijk
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

8.  Lack of association between miR-218 rs11134527 A>G and Kawasaki disease susceptibility.

Authors:  Lei Pi; Lanyan Fu; Yufen Xu; Di Che; Qiulian Deng; Xijing Huang; Meiai Li; Li Zhang; Ping Huang; Xiaoqiong Gu
Journal:  Biosci Rep       Date:  2018-05-22       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.